![]() ![]() The bankruptcy of Endo, an Ireland-based company with its U.S. ![]() headquarters in Malvern, Pa., would facilitate the settlement. “By definitively addressing the more than $8 billion of debt that has burdened our balance sheet and establishing a pathway to closure with respect to the thousands of opioid-related and other lawsuits that the company has been defending at an unsustainable cost, we will be able to move forward as a new Endo and reach our full potential,” Endo Chief Executive Officer and President Blaise Coleman said in a statement. The settlement, which is contingent on final documentation and bankruptcy court approval, would require the $450 million to be paid in cash over 10 years to participating states and “subdivisions.” In addition to permanently banning Endo’s opioid marketing, it would mandate that the company turn over opioid-related documents for publication in an online archive and pay $2.75 million for archival expenses.Īsked about how much Connecticut might receive from the settlement, a spokesperson for Tong said that it was “too soon to say on state-specific amounts.” The archive bridgeport full# ![]() While Connecticut does not have any pending lawsuits against Endo related to its role in the opioid crisis, it is still participating in the settlement negotiations with the company. 9 things to know about CT state troopers' fake ticket scheme.Dentist was ‘lying in wait’ for woman before murder-suicide, Wethersfield chief says. ![]()
0 Comments
Leave a Reply. |